Effectiveness and Adverse Effects of Risperidone in Children with Autism Spectrum Disorder in a Naturalistic Clinical Setting at a University Hospital in Oman

Table 1

Baseline descriptive statistics by sex of children with autism spectrum disorder who had at least one year of follow-up after being initiated on risperidone treatment.

Variable	Males (n = 72), Mean (SD)	Females (n = 23), Mean (SD)	T-test value
Mean (SD) age at starting risperidone, years = 9.47 (3.66)	9.14 (3.67)	10.52 (3.50)	0.115
Mean (SD) dose of risperidone, mg/day = 1.04 (0.91)	1.05 (0.93)	1.03 (0.85)	0.954
Mean (SD) duration of treatment, months = 38.57 (28.81)	36.31 (21.07)	45.65 (23.03)	0.073

SD = standard deviation.